Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Regulatory Updates

PHSS Regulatory Update February 2015

03 February 2015   (0 Comments)
Posted by: Tamsin Marshall
Share |

PHSS Regulatory Update February 2015   


During the last 4 weeks there have been a number of developments in the regulation of the pharmaceutical industry. This month a number of important product issues are also noted.

The topics covered in this edition of the “Update” include:


  • 3 PhEur monographs suppressed
  • MHRA GMP data integrity definitions and guidance for industry
  • MHRA Devices Online Registration System (DORS)
  • MHRA helps pharmaceutical companies develop European (UK) innovative technology sites



  • Launch of office of pharmaceutical quality
  • New & revised draft guidances CDER is planning to publish during calendar year 2015
  • Draft Guidance for Industry -CGMP requirements for combination products




  • ICH Q3D Guideline on Elemental Impurities



  • Mexico applies for PIC/S membership



  • UK recall of oral diclofenac presentations with legal status ‘P’
  • FDA’s investigation into patients being injected with simulated IV fluids continues
  • Determination that Tagamet (cimetidine) tablets and other drug products were not withdrawn from sale for reasons of safety or effectiveness
  • GVK Biosciences Hyderabad: EMA recommends suspending medicines over flawed studies
  • Stronger advice on the use of valproate medicines in women



  • New Orange and Green Guides 2015

Membership Software Powered by YourMembership  ::  Legal